Silverback Therapeutics Inc
Silverback Therapeutics Inc Stock, NASDAQ:SBTX
Silverback Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases. The company was founded by Peter A. Thompson in 2016 and is headquartered in Seattle, WA.